View in EDS

Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.

Saved in:
Bibliographic Details
Title: Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
Authors: Schewe DM; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Vogiatzi F; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Münnich IA; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Zeller T; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Windisch R; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Wichmann C; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Müller K; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Bhat H; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Felix E; Medical Faculty Otto-von-Guericke University Magdeburg Germany., Mougiakakos D; Department of Hematology/Oncology Otto-von-Guericke University Magdeburg Germany., Bruns H; Department of Internal Medicine 5, Hematology and Oncology Friedrich-Alexander-University Erlangen-Nürnberg Erlangen Germany., Lenk L; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Humpe A; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany., Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany., Kellner C; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.
Source: HemaSphere [Hemasphere] 2024 Feb 22; Vol. 8 (2), pp. e48. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38435424
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schewe+DM%22">Schewe DM</searchLink>; Medical Faculty Otto-von-Guericke University Magdeburg Germany.<br /><searchLink fieldCode="AU" term="%22Vogiatzi+F%22">Vogiatzi F</searchLink>; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Münnich+IA%22">Münnich IA</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.<br /><searchLink fieldCode="AU" term="%22Zeller+T%22">Zeller T</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.<br /><searchLink fieldCode="AU" term="%22Windisch+R%22">Windisch R</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.<br /><searchLink fieldCode="AU" term="%22Wichmann+C%22">Wichmann C</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.<br /><searchLink fieldCode="AU" term="%22Müller+K%22">Müller K</searchLink>; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Bhat+H%22">Bhat H</searchLink>; Medical Faculty Otto-von-Guericke University Magdeburg Germany.<br /><searchLink fieldCode="AU" term="%22Felix+E%22">Felix E</searchLink>; Medical Faculty Otto-von-Guericke University Magdeburg Germany.<br /><searchLink fieldCode="AU" term="%22Mougiakakos+D%22">Mougiakakos D</searchLink>; Department of Hematology/Oncology Otto-von-Guericke University Magdeburg Germany.<br /><searchLink fieldCode="AU" term="%22Bruns+H%22">Bruns H</searchLink>; Department of Internal Medicine 5, Hematology and Oncology Friedrich-Alexander-University Erlangen-Nürnberg Erlangen Germany.<br /><searchLink fieldCode="AU" term="%22Lenk+L%22">Lenk L</searchLink>; Department of Pediatrics, ALL-BFM Study Group Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Valerius+T%22">Valerius T</searchLink>; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Humpe+A%22">Humpe A</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.<br /><searchLink fieldCode="AU" term="%22Peipp+M%22">Peipp M</searchLink>; Division of Antibody-Based Immunotherapy, Department of Medicine II Christian-Albrechts University and University Hospital Schleswig-Holstein Kiel Germany.<br /><searchLink fieldCode="AU" term="%22Kellner+C%22">Kellner C</searchLink>; Division of Transfusion Medicine, Cell Therapeutics and Haemostaseology LMU University Hospital, LMU Munich Munich Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101740619%22">HemaSphere</searchLink> [Hemasphere] 2024 Feb 22; Vol. 8 (2), pp. e48. <i>Date of Electronic Publication: </i>2024 Feb 22 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101740619 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2572-9241 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225729241%22">25729241 </searchLink><i>NLM ISO Abbreviation: </i>Hemasphere <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38435424
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/hem3.48
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e48
    Titles:
      – TitleFull: Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schewe DM
      – PersonEntity:
          Name:
            NameFull: Vogiatzi F
      – PersonEntity:
          Name:
            NameFull: Münnich IA
      – PersonEntity:
          Name:
            NameFull: Zeller T
      – PersonEntity:
          Name:
            NameFull: Windisch R
      – PersonEntity:
          Name:
            NameFull: Wichmann C
      – PersonEntity:
          Name:
            NameFull: Müller K
      – PersonEntity:
          Name:
            NameFull: Bhat H
      – PersonEntity:
          Name:
            NameFull: Felix E
      – PersonEntity:
          Name:
            NameFull: Mougiakakos D
      – PersonEntity:
          Name:
            NameFull: Bruns H
      – PersonEntity:
          Name:
            NameFull: Lenk L
      – PersonEntity:
          Name:
            NameFull: Valerius T
      – PersonEntity:
          Name:
            NameFull: Humpe A
      – PersonEntity:
          Name:
            NameFull: Peipp M
      – PersonEntity:
          Name:
            NameFull: Kellner C
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 02
              Text: 2024 Feb 22
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2572-9241
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: HemaSphere
              Type: main
ResultId 1